Tag Archives: global diabetes summit

Getting Teens Thinking Healthy, Helping Them COPE

In a crowd-favorite presentation during the Global Diabetes Summit, Bernadette Melnyk said, we all know people don’t change behavior easily, which is why she has focused much of her career on helping teens making healthy behavior changes to help them live healthier with a focus on mental health.

17 percent of teens are obese or overweight, but one in four adolescents has a mental health problem and less than 25 percent receive any treatment. According to Melnyk, substantial studies that shows that in overweight teens, the more likely they are to have a mental health disorder. These mental health conditions make it hard for teens to picture themselves even living healthy lifestyles. And in many studies when behaviors have been modified in studies and short-term gains have been achieved in high-risk populations, teens gained the weight back.

Melnyk’s secret sauce to this problem is her COPE program, which focuses on thinking, emotion, exercise, nutrition in hopes of decreasing teen’s doubts and increasing their ability make changes. In other words, if you teach teens to think differently, they can act differently. 

In each session, after working on goal setting, emotional coping skills, behavior therapy and more, the teens get up and moving with a “wheel of fitness” where they learn various activities and movement, which are all designed to be done in the middle of the classroom. They also learn about nutrition like social eating, portion sizes and nutrition labels. In the final sessions of the after-school program, they integrate how to put all these together and help the teens make a lifestyle plan.

Melnyk’s study showed many positives results from a decrease in BMI to decreases in depressive and anxiety symptoms. The purpose of her current study is to evaluate the efficacy of COPE/Healthy Lifestyles TEEN (thinking, emotions, exercise and nutrition) program on the healthy lifestyle behaviors, BMI, mental health and academic outcomes of 779 high school 14-16 year old adolescents.   The key regarding many of these findings in implementation. So she said: why does this matter to schools and why should they enact the COPE program?

She is also measuring academic outcomes and found that because of the cognitive behavioral skills the teens learned, they can improve their academic skill level because of the confidence and coping skills they learn in the program.

The COPE program will be used as either a preventive or management intervention program for overweight/obesity in adolescents. The program is now being developed so that it can be implemented in schools across the country. Her work in also now ongoing to adapt the program for school-age child and college-age youth.

Has focusing on your mental health ever helped you through an illness? How can we get more teens to learn the importance of improving their mental health?

National Research Battling Diabetes On Multiple Fronts

Federally funding basic and clinical research isn’t enough to stem the tide of Type 2 diabetes, says Griffin Rodgers, director of the National Institute of Diabetes and Digestive and Kidney Diseases. The federal government also must – and does – support efforts to get the results into public hands.

Speaking at the 2012 Global Diabetes Summit hosted by the Ohio State’s Diabetes Research Center at Wexner Medical Center, Rodgers outlined the research efforts of the federal agency responsible for diabetes as well as numerous related conditions, including kidney disease and obesity.

Because of those multiple areas of research, Rodgers said the agency’s approach is integrated, recognizing that in the United States, Type 2 diabetes is the leading cause of kidney disease, which can have an amplifying effect on cardiovascular complications.

“These diseases are common, costly and consequential,” he said.

Prevention of diabetes is a significant national effort. While about 26 million Americans have diabetes, 79 million have prediabetes – meaning their blood sugar is higher than normal but not high enough to trigger the diabetes diagnosis. They are considered at highest risk for developing diabetes.

The decade-old Diabetes Prevention trial showed that a lifestyle intervention emphasizing dietary changes and 150 minutes of physical activity per week was highly effective at delaying or preventing the onset of diabetes in high-risk individuals compared to a drug, metformin, or no intervention at all. The lifestyle intervention showed a 58 percent reduction in diabetes onset, compared to a 31 percent reduction for those on metformin. A follow-up showed that the results can be sustained in the long term. Among participants who were 65 or older, the reduction was 71 percent.

Women who develop gestational diabetes during pregnancy are also considered a high-risk group under study for the most effective interventions. Research suggests that children born to these women are at higher risk, as well, for developing Type 2 diabetes.

In addition, children are being watched closely as experts grow increasingly concerned about weight issues in youths. Researchers are seeing an increase in the prevalence of Type 2 diabetes in the pediatric population, Rodgers noted, which indicates that the need for prevention interventions must start earlier in life. A middle-school-based program helped children lower weight, but not any more than could be attributed to chance.

“Not only does one have to intervene in schools, but also in other settings,” Rodgers said.

Perhaps the biggest challenge is engaging potential intervention participants – which is why sharing information about research results is so vital.

“Fundamentally, if one is funding studies that develop the acquisition of knowledge and subsequently transformation of that data into knowledge that can affect patients, if one doesn’t also invest in dissemination, one is in a sense leaving at the table discoveries as well as efficiencies,” he said. “Not only is it important to fund clinical research, but also the dissemination of information to individuals so that we might make a substantial public health impact.”

-Emily Caldwell

Evidenced-based, Personalized, and Lifestyle Approaches to Diabetes

The following highlights some of the sessions at the 2012 Global Diabetes Summit, hosted by Ohio State’s Diabetes Research Center at Wexner Medical Center.

Look AHEAD — what were the takeaways?

We have had much pharmaceutical successes in working towards a cure for diabetes — every year or two we have one or two new drugs for treatment. But researchers hypothesized intensive lifestyle interventions might be the key for the management of diabetes specifically for preventing cardiovascular disease.

Samuel Dagogo-Jack, MD, DM, FRCP, discussed the recent study which sought to prove just that, called “Look AHEAD. ” This trial implimented lifestyle-intervention programs which were focused on helping patients with Type 2 diabetes lose weight.

While there were many benefits, the study did not show that weight loss lowers heart disease risk in type 2 diabetes management as predicted, which examined this topic for 11 years — the longest diabetes study that looked specifically at weight management to help prevent cardiovascular disease in patients with Type 2 diabetes.

What they did find was improvements in glycemic control, blood pressure, HDL cholestorol (or good cholestrol), sleep apnea, and many other health benefits by participating in a management program.

Dagogo-Jack says that interventions may have started too late or that it ended too early. In the future, they also want to consider how statin use affected the weight management and other risk-factors which may not have been considered. Dagogo-Jack  says the jury is still out and the importance of weight loss should not be dismissed. Stay tuned for additional data and in the meantime, “keep your health in check.”

Lifestyle Intervention Changes in Arab-Americans

Linda Jaber, PharmaD, presented on lifestyle changes which effectively helped Arab-Americas in her study with weight loss/management which is a key risk factor for Type 2 Diabetes. The educational intervention in an Arab-American population focused on educating around lifestyle intervention that was cultural sensitive and scalabile.

The education was group-delivered, family-centered and the strategies offered were culturally-specific and sensitive to the needs of the population. Another successful strategy was involving participants to act as coaches by sharing success stories with the group. Since a majority of the participants were Muslim, the education had specific strategies for fasting during Ramadan.

Many people met a 7 percent weight loss goal set by the study. By encouraging participants to reduce fat intake, they were able to reduce calories with simple modification of ethnic foods and portion control for participants. They also found that family support was a significant predictor of weight-loss support, 70 percent of people who achieved the weight-loss goal had family support.

In summary, a culturally-appropriate, group lifestyle intervention implemented in a community setting was feasible and effective in helping to prevent diabetes risk factors in Arab-American patients.

Ohio State’s Wexner Medical Center a Hub for Diabetes Experts Around the World

The Second Global Diabetes Summit will be held Nov. 14 – 16 at the Ohio Union presented by Ohio State’s Diabetes Research Center. The summit theme is, “New Horizons in Diabetes: Genetic to Personalized Health Care,” and will be led by a variety of diabetes physicians, researchers and advocates regarding the latest research on prevention, diabetes technology, cellular and tissue therapies, islet cell therapy, pharmacology, pregnancy and cardiovascular disease and other relevant topics.  Notable speakers include:

  • Ann Albright, PhD, RD – Director of Diabetes Translation, Centers for Disease Control and Prevention who will discuss the research behind The U.S. National Diabetes Prevention Program
  • Jean–Claude Mbanya, MD, PhD, FRCP –  President, International Diabetes Federation will focus on the global pandemic of obesity and diabetes in adults, include epidemiological solutions and challenges, and the global economic impact of diabetes
  • Vivian Fonseca, MD, FRCP – President, American Diabetes Association, who will discuss future oral anti-diabetic medications
  • Griffin Rodgers, MD, MBA, MACP –  Director, The National Institute of Diabetes and Digestive and Kidney Diseases will present on genomics and diabetes

To view a complete agenda and register, visit http://go.osu.edu/diabetessummit.

In addition, on the final day of the summit, Saturday, November 17, a Community Event themed “Focus on Health and Wellness: Life Choices”, will be held at Veterans Memorial Auditorium located at 300 W. Broad St. This event will give community members the opportunity to ask one-on-one questions, view exercise and cooking demonstrations, experience hands on workshops and listen to panel discussions featuring diabetes experts.

Celebrity guests includeNBA Hall of Fame legend and vice president of Basketball for Atlanta Hawks, Dominique Wilkins; and Oscar Joyner, president and Chief Operating Officer of REACH Media, Inc. and son of Tom Joyner, who will speak on their personal battles with diabetes and successful management of this disease.

The community event, is FREE and open to the public, but pre-registration is required. Lunch will be served to all registered attendees.

To register for the community event, visit http://go.osu.edu/GDSCommunity or call 614-273-1400.

If you would like to donate your time as a clinical or non-clinical volunteer for the Global Diabetes Summit, contact Dorian Harriston, senior marketing manager, at Dorian.Harriston@osumc.edu.